Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
340.90
-4.65 (-1.35%)
Mar 28, 2025, 3:29 PM IST

Biocon Statistics

Total Valuation

Biocon has a market cap or net worth of INR 408.95 billion. The enterprise value is 607.42 billion.

Market Cap 408.95B
Enterprise Value 607.42B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date Apr 25, 2025
Ex-Dividend Date Jul 5, 2024

Share Statistics

Biocon has 1.20 billion shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class n/a
Shares Outstanding 1.20B
Shares Change (YoY) +0.11%
Shares Change (QoQ) -2.89%
Owned by Insiders (%) 62.53%
Owned by Institutions (%) 22.34%
Float 444.31M

Valuation Ratios

The trailing PE ratio is 50.92 and the forward PE ratio is 56.63. Biocon's PEG ratio is 1.58.

PE Ratio 50.92
Forward PE 56.63
PS Ratio 2.77
PB Ratio 2.00
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio 1.58
Financial Ratio History

Enterprise Valuation

EV / Earnings 75.52
EV / Sales 4.11
EV / EBITDA 18.47
EV / EBIT 43.48
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.63
Debt / EBITDA 5.10
Debt / FCF n/a
Interest Coverage 1.53

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 2.03%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 9.05M
Profits Per Employee 492,982
Employee Count 16,315
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +32.85% in the last 52 weeks. The beta is 0.43, so Biocon's price volatility has been lower than the market average.

Beta (5Y) 0.43
52-Week Price Change +32.85%
50-Day Moving Average 350.64
200-Day Moving Average 352.02
Relative Strength Index (RSI) 51.25
Average Volume (20 Days) 2,358,315

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Biocon had revenue of INR 147.62 billion and earned 8.04 billion in profits. Earnings per share was 6.71.

Revenue 147.62B
Gross Profit 90.23B
Operating Income 14.00B
Pretax Income 17.19B
Net Income 8.04B
EBITDA 32.45B
EBIT 14.00B
Earnings Per Share (EPS) 6.71
Full Income Statement

Balance Sheet

The company has 26.50 billion in cash and 167.71 billion in debt, giving a net cash position of -141.21 billion or -117.98 per share.

Cash & Cash Equivalents 26.50B
Total Debt 167.71B
Net Cash -141.21B
Net Cash Per Share -117.98
Equity (Book Value) 267.20B
Book Value Per Share 170.57
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 61.13%, with operating and profit margins of 9.48% and 5.45%.

Gross Margin 61.13%
Operating Margin 9.48%
Pretax Margin 11.64%
Profit Margin 5.45%
EBITDA Margin 21.98%
EBIT Margin 9.48%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.15%.

Dividend Per Share 0.50
Dividend Yield 0.15%
Dividend Growth (YoY) -66.67%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.11%
Shareholder Yield 0.04%
Earnings Yield 1.97%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.

Last Split Date Jun 12, 2019
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a